Research

The impact of COVID-19 on routine patient care from a laboratory perspective

E C Kruger, R Banderker, R T Erasmus, A E Zemlin

Abstract


Background. Globally, few studies have examined the effect of the COVID-19 pandemic on routine patient care and follow-up.

Objectives. To evaluate the effect of the COVID-19 response on biochemical test requests received from outpatient departments (OPDs) and peripheral clinics serviced by the National Health Laboratory Service Chemical Pathology Laboratory at Tygerberg Hospital, Cape Town, South Africa (SA). Request volumes were used as a measure of the routine care of patients, as clinical information was not readily available.

Methods. A retrospective audit was conducted. The numbers of requests received from OPDs and peripheral clinics for creatinine, glycated haemoglobin (HbA1c), lipid profiles, thyroid-stimulating hormone (TSH), free thyroxine, free tri-iodothyronine (fT3), serum and urine protein electrophoresis, serum free light chains and neonatal total serum bilirubin were obtained from 1 March to 30 June for 2017, 2018, 2019 and 2020.

Results. The biggest impact was seen on lipids, creatinine, HbA1c, TSH and fT3. The percentage reduction between 1 March and 30 June 2019 and between 1 March and 30 June 2020 was 59% for lipids, 64% for creatinine and HbA1c, 80% for TSH and 81% for fT3. There was a noteworthy decrease in overall analyte testing from March to April 2020, coinciding with initiation of level 5 lockdown. Although an increase in testing was observed during June 2020, the number of requests was still lower than in June 2019.

Conclusions. This study, focusing on the short-term consequences of the SA response to the COVID-19 pandemic, found that routine follow-up of patients with communicable and non-communicable diseases was affected. Future studies are necessary to evaluate the long-term consequences of the pandemic for these patient groups.

 


Authors' affiliations

E C Kruger, Division of Chemical Pathology, Department of Pathology, National Health Laboratory Service, Tygerberg Hospital and Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa

R Banderker, Division of Chemical Pathology, Department of Pathology, National Health Laboratory Service, Tygerberg Hospital and Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa

R T Erasmus, Division of Chemical Pathology, Department of Pathology, National Health Laboratory Service, Tygerberg Hospital and Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa

A E Zemlin, Division of Chemical Pathology, Department of Pathology, National Health Laboratory Service, Tygerberg Hospital and Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa

Full Text

PDF (180KB)

Keywords

Coronavirus disease; COVID-19 pandemic; Follow-up; Communicable disease; Non-communicable disease; Audit

Cite this article

South African Medical Journal 0;0(0):.

Article History

Date submitted: 2020-11-05
Date published: 2020-11-05

Article Views

Abstract views: 159
Full text views: 55

Comments on this article

*Read our policy for posting comments here